Improved Metabolic and Brain Health Obesity itself is associated with: Chronic inflammation Insulin resistance Hormonal dysregulation Increased depression and anxiety risk Improving metabolic health may indirectly improve mood and cognitive function in some patients
An analysis of electronic health records from over 26,000 adults with obesity and at least one autoimmune disease has shown that those taking GLP-1 medication experienced fewer cardiac events, were less likely to visit the ER, and had a lower risk of death
The technique ensures that the drug meets required specifications for safety and efficacy
If your plan has one: Standard prior authorization for Wegovy will be denied Appeals are usually unsuccessful (exclusions are plan design decisions) Alternative coverage pathways may exist (cardiovascular or sleep apnea indications) If your plan excludes weight loss coverage, Wegovy has a cardiovascular indication and Zepbound has a sleep apnea indication
Retatrutide has been associated with superior fat loss in trouble spots such as the belly and liver
Free Radic Biol Med 65:509527 Chico L, Modena M, Gerfo AL, Ricci G, Ienco EC, Ryskalin L, Fornai F, Siciliano G (2017) Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis